Review
Open access
Sep 2026
Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicity in Melanoma: Current Evidence and Practical Clinical Management
Simple Summary Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced melanoma, leading to substantial and durable improvements in patient survival. However, these agents may also trigger immune-related cardiovascular toxicities, which, although uncommon, can be severe and potentially fatal....
Andrea Bottardi, Gabriele Busin, Lam Nguyen et al.
· Cancers · 0 citations